Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Aerie

14 best black swimsuits that are utterly timeless and exude 'Quiet Luxury'

A summer essential, these are the best black swimsuits to shop right now

Woman & Home

15 best one-piece swimsuits that’ll make you want to book a vacation

The best one-piece swimsuits deliver on design, fabric and fit for a failsafe pool-side look

Woman & Home

The 28 most famous plus size models in the world - and how to follow them

These are 28 of the most famous plus size models in the world from Ashley Graham to Tess Holliday

Woman & Home

From analysis to the latest developments in health,
read the most diverse news in one place.

Aerie links with disability-focused Liberare for sexy, accessible intimates

Its partnership with intimates label Liberare focuses on accessibility first.

Input

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has cleared the Eledon Pharmaceuticals’ (NASDAQ:ELDN) Investigational New Drug (IND) application to evaluate Tegoprubart for the prevention of organ rejection in patients receiving a kidney transplant. Eledon shares traded in a range of $2.89 to $3.16 on a day volume of 31.27 thousand…

Benzinga

Aerie Pharmaceuticals Begins Patient Dosing In Late-Stage Dry Eye Disease Study

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) has dosed the first patient in the Phase 3 COMET-2 study to evaluate AR-15512 ophthalmic solution as a treatment for the signs and symptoms of dry eye disease (DED).

Benzinga

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

US Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.